Find a trial

AMLM22/D1

The International Acute myeloid leukaemia (AML) Platform Consortium (IAPC) trial is a randomised, multi-arm study platform to compare the efficacy of experimental therapies versus standard of care in patients with acute myeloid leukaemia in first complete remission

Locations Wesley, Southport, South Brisbane, Chermside

Diagnosis Leukaemia

CATALINA-2 / TORL123-002

A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer

Locations Chermside

Diagnosis Ovarian cancer

EIK1001-006

Safety and Efficacy of EIK1001-006 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma

Locations Chermside

Diagnosis Skin cancer – melanoma

EvoPAR-Prostate01 / D9723C00001

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician’s Choice New Hormonal Agents

Locations Chermside, Adelaide

Diagnosis Prostate cancer

DESTINY-BTC01 / D781PC00001

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Locations Chermside

Diagnosis Advanced solid tumours

eVOLVE-RCC02 / D798NC00001

A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC

Locations Chermside, Adelaide

Diagnosis Kidney cancer